Dr Reddys Laboratories Share Price Today - Live Blog for August 13, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.08% drop, and it's now trading at ₹1,254.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.22%. At this moment, it's actively trading at ₹1,253.15, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd witnessed a notable 0.06% surge in its share price and is presently trading at ₹1,250.40, captivating the attention of market participants.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,250.45. Investors should examine the factors driving this decline. The stock's PE ratio is 17.9300, whereas the industry PE ratio stands at 33.6700.

After a significant 0.11% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,251.10 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.14% recently. As of now, this stock is actively trading at a current market price of ₹1,249.75 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd witnessed a -0.06% drop in its share price and is currently trading at ₹1,248.75. With the stock's PE at 17.9300 and the industry PE at 33.6700, investors are weighing their options.

Dr Reddys Laboratories Ltd shares experienced a -0.08% reduction, with the current market price at ₹1,250.75. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,250.25, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd observed a -0.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,252.15. The stock has a PE ratio of 17.9300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.02%, with the current market value at ₹1,252.15 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.15%, reaching the current market price of ₹1,251.60. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.28% increase and currently trading at ₹1,249.70 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.28%, reaching the current market price of ₹1,249.70. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd experienced a substantial 0.28% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,249.70, making it an appealing option for investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.28% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,249.70, making it an appealing option for investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.28%, with its current market value per share resting at ₹1,249.70. This development highlights the stock's appeal to investors.

Demonstrating a commendable 0.63% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,246.25. In terms of valuation, the stock maintains a PE ratio of 17.9300, while the industry PE ratio stands at 33.6700.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.63% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,246.25 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.22% upswing, and it's currently trading at ₹1,238.00 per share. Investors are closely watching this development.

With a -0.23% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,235.25. Investors should examine the factors driving this decline. The stock's PE ratio is 17.9300, whereas the industry PE ratio stands at 33.6700.

Dr Reddys Laboratories Ltd witnessed a substantial 0.05% increase in its share price and is currently trading at ₹1,233.60. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.04% increase in its share price and is currently trading at ₹1,233.00. This remarkable performance has caught the eye of investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.10%, with its current market value per share resting at ₹1,232.20. This development highlights the stock's appeal to investors.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,230.60. Investors should examine the factors driving this decline. The stock's PE ratio is 17.9300, whereas the industry PE ratio stands at 33.6700.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.11% uptick in its share price. As a result, it's now actively trading at ₹1,230.00 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.16% increase. Presently, it is actively trading at ₹1,228.55.

After a significant 0.13% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,226.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.13% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,226.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.14%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,226.00 per share.

Dr Reddys Laboratories Ltd's share price has experienced a notable 1.17% upswing, and it's currently trading at ₹1,224.20 per share. Investors are closely watching this development.